Normal hemostasis represents a balance between platelet Tx A2 formation and vessel wall PG-12 production that theoretically could lead to thrombosis on one hand or bleeding on the other whenever an imbalance occurs. A corollary to this postulate implies that selective inhibition of thromboxane synthesis with maintenance of prostacyclin production may offer a new therapeutic approach to the prevention of thrombosis.